Crinetics Pharmaceuticals, Inc.

Nasdaq:CRNX

Pharmaceutical Preparations·SAN DIEGO, CA

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F.

CEO

Struthers Richard Scott

CFO

Schilke Tobin

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/26/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	2/27/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

22 shown

Filed	Period
2/26/26	Q1 FY2026	→
1/13/26	Q4 FY2026	→
1/5/26	Q4 FY2026	→
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
↓

News (8-K)

58 shown

Filed	Type	Description
3/3/26	Other	Changes in Registrant's Certifying Accountant	→
1/26/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/7/26	Other	Other Events	→
12/17/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/26/25	Reg FD	Regulation FD Disclosure	→
6/30/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

36 shown

Filed	Form	Description
2/26/26	S-8	S-8	→
1/7/26	424B5	424B5	→
1/5/26	424B5	424B5	→
4/23/25	ARS	ARS	→
2/27/25	S-8	S-8	→
10/9/24	424B5	424B5	→
↓

Filing History(646 filings)

TypeDateAccessionPeriodSize

Mar 13, 2026

0001628280-26-017797FORM 4

Mar 12, 2026

6.7 KB

144

Mar 12, 2026

0001950047-26-002543

—

4.6 KB

Mar 4, 2026

0001628280-26-014775FORM 4

Mar 3, 2026

4.8 KB

Mar 4, 2026

0001628280-26-014772FORM 4

Mar 3, 2026

5.2 KB

144

Mar 3, 2026

0001950047-26-002102

—

4.6 KB

8-K

Mar 3, 2026

0001658247-26-0000178-K

Feb 27, 2026

143.7 KB

144

Mar 2, 2026

0001628280-26-013047

—

4.4 KB

S-8

Feb 26, 2026

0001658247-26-000014S-8

—

252.8 KB

10-K

Feb 26, 2026

0001658247-26-00001210-K

Dec 31, 2025

9.8 MB

8-K

Feb 26, 2026

0001658247-26-0000118-K

Feb 26, 2026

288.2 KB

Feb 25, 2026

0001628280-26-011730FORM 4

Feb 23, 2026

10.3 KB

Feb 25, 2026

0001628280-26-011728FORM 4

Feb 23, 2026

7.0 KB

Feb 25, 2026

0001628280-26-011723FORM 4

Feb 23, 2026

7.0 KB

Feb 25, 2026

0001628280-26-011718FORM 4

Feb 23, 2026

6.9 KB

Feb 25, 2026

0001628280-26-011715FORM 4

Feb 23, 2026

6.9 KB

SCHEDULE 13G/A

Feb 5, 2026

0000908834-26-000040

—

61.0 KB

144

Feb 2, 2026

0001950047-26-000824

—

6.9 KB

8-K

Jan 26, 2026

0001658247-26-0000038-K

Jan 20, 2026

136.1 KB

8-K

Jan 13, 2026

0001193125-26-0118728-K

Jan 13, 2026

6.4 MB

Jan 7, 2026

0001628280-26-001230FORM 4

Jan 5, 2026

8.7 KB

8-K

Jan 7, 2026

0001193125-26-0064218-K

Jan 5, 2026

466.2 KB

424B5

Jan 7, 2026

0001193125-26-006276424B5

—

656.0 KB

144

Jan 5, 2026

0001950047-26-000146

—

4.6 KB

424B5

Jan 5, 2026

0001193125-26-002458424B5

—

514.6 KB

8-K

Jan 5, 2026

0001193125-26-0023688-K

Jan 5, 2026

11.8 MB

25 filings shown

Filed	Form	Description
5/20/25	DEFA14A	DEFA14A	→
4/23/25	DEFA14A	DEFA14A	→
4/23/25	DEF 14A	DEF 14A	→
4/25/24	DEFA14A	DEFA14A	→
4/25/24	DEF 14A	DEF 14A	→
4/27/23	DEFA14A	DEFA14A	→
↓

Crinetics Pharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(646 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/13/26	4	4	→
3/4/26	4	4	→
3/4/26	4	4	→
2/25/26	4	4	→
2/25/26	4	4	→
2/25/26	4	4	→
↓

Filed	Form	Description
3/12/26	144	144	→
3/3/26	144	144	→
3/2/26	144	144	→
2/5/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/2/26	144	144	→
1/5/26	144	144	→
↓